Indonesia akan jadi Tempat Uji Coba Vaksin TBC yang Dikembangkan Bill Gates | Kabar Siang tvOne

Summary

President Prabowo Subianto announced that Indonesia will be the testing ground for a new tuberculosis (TB) vaccine developed with the support of the Bill & Melinda Gates Foundation. The trial, which is already in its final clinical stage, aims to reduce Indonesia's high TB-related death rate. Health experts, including Dr. Erlina Burhan, emphasized the vaccine's promising safety and effectiveness. While some public skepticism surrounds the trial, it is seen as a vital step toward eliminating TB globally. Indonesia's involvement in this global initiative is seen as both a contribution to science and a potential boost to domestic vaccine production.

Takeaways

• 😀 President Prabowo Subianto announced that Indonesia would be the testing ground for a tuberculosis (TB) vaccine developed by the Bill and Melinda Gates Foundation.
• 😀 The trial is aimed at reducing the high TB death rate in Indonesia, which currently claims around 100,000 lives annually.
• 😀 Health Minister Budi Gunadi Sadikin emphasized the importance of TB vaccination and acknowledged that the vaccine may not fully eliminate TB but has proven effectiveness.
• 😀 The goal is for Indonesia to be TB-free by 2030, in line with the World Health Organization's (WHO) target.
• 😀 Clinical trials for the TB vaccine are currently in phase 3, with over 2,000 injections already administered in Indonesia.
• 😀 While some members of society are skeptical of the vaccine, the government reassures the public that safety and effectiveness are being rigorously tested in trials.
• 😀 Dr. Erlina Burhan, a key researcher in the vaccine trial, clarified that the vaccine was not created by Bill Gates but has been funded by the Bill and Melinda Gates Foundation for its development.
• 😀 Indonesia's participation in the trial is significant as the country ranks second in the world for the TB burden, with over 90,000 cases and 100,000 deaths each year.
• 😀 The vaccine, named M72, targets adolescents and adults, as the BCG vaccine used in children under five does not provide adequate protection for older populations.
• 😀 Dr. Burhan emphasized that the vaccine is safe, with no dangerous side effects reported, and that there is significant potential for positive global impact if the vaccine proves successful.

Q & A

What is the purpose of the tuberculosis (TB) vaccine trial in Indonesia?

The purpose of the TB vaccine trial in Indonesia is to test a new vaccine developed by the Gates Foundation, which aims to reduce the high death rate caused by tuberculosis in the country.

Why was Indonesia chosen as the location for the TB vaccine trial?

Indonesia was chosen due to its high burden of tuberculosis, with an estimated 90,000 cases per year and a death toll of over 100,000 annually, making it a critical location for the trial.

How does President Prabowo Subianto view the TB vaccine trial?

President Prabowo Subianto is committed to reducing the death rate from tuberculosis in Indonesia and supports the TB vaccine trial as a step toward addressing the national health challenge.

What concerns have been raised by the public regarding the TB vaccine trial?

There have been concerns about the safety of the vaccine, with some people fearing that Indonesia may become a 'guinea pig' for the trial and expressing uncertainty about potential long-term side effects.

What is the role of Dr. Erlina Burhan in the TB vaccine research?

Dr. Erlina Burhan is the main national researcher in Indonesia for the M72 vaccine, and she is involved in conducting research on the vaccine's safety and effectiveness.

How long has the TB vaccine research been underway?

The TB vaccine research started in 1999 and took several years of testing on laboratory animals before moving on to human clinical trials in the 2000s. It is currently in phase 3 of clinical trials.

What is the effectiveness and safety of the TB vaccine based on initial trials?

Initial trials in phase 1 and 2 have shown promising results, with the vaccine demonstrating a 50% effectiveness and good safety tolerance in the small groups tested.

How many people have participated in the TB vaccine trial, and how many are from Indonesia?

The trial aims to involve 20,000 participants, with 2,095 of them being from Indonesia. The trial is set to continue until 2028.

What are the expected outcomes of the TB vaccine trial in Indonesia?

The trial aims to determine the vaccine's long-term effectiveness and safety, with the hope that it will be proven safe and effective in preventing tuberculosis, particularly in adolescents and adults.

What role does the Gates Foundation play in the TB vaccine trial?

The Gates Foundation funds the TB vaccine trial but did not create the vaccine. It supports the research by providing financial backing for the clinical trials in various countries.